Biozenta pursuing and exporting to over 30+ countries across the continents globally which include Asia, Africa, LATAM, CIS, MENA and Europe. With over 180+ international product registrations (many more are under registrations), Biozenta is emerging as one of the leading and fast growing major Indian pharmaceutical manufacturer and exporter. Biozenta is aggressively participating in all the Govt, MOH and local tenders of pharmaceutical formulations, across the globe.
In the mark to be global player, Biozenta has focused on global accreditations right from its inception. With the state-of-the-art multi-locational EU-GMP approvable facilities, WHO GMP and PICs approved, Biozenta also has various approvals from Kenya, Malawi, Myanmar, Yemen, Ivory Coast, Uganda and various other countries and pursuing EUGMP and many other countries approvals under process:
World Health Organization
State GMP/ GLP
Pharmacy & Poison Board (Kenya)
Supreme Board of Drugs and Medical Appliances (Yemen)
Department Of Drugs And Food Essential Drugs Bureau (Cambodia)
DIGMID (Dirección General de Medicamentos, Insumos y Drogas) –PERU
Liberia (Certificate is awaited)
Pharmacy and Medicines Regulatory Authority-Malawi
Food and Drug Administration, Philippine
National Medicines Regulatory Authority, (NMRA) Srilanka
Department of Drug Administration (Nepal)
Food, Medicine and Health Care Administration and Control Authority (FMHACA) Ethiopia
Tanzania Medicines and Medical Devices Authority (TMDA)
Ministry of Health of the Russian Federation (Minzdrav), Russia
Cuba
Colombia
Mangolia
Angola
Sri Lanka
Myanmar
Venezuela
Panama
Nepal
Bolivia
Pakistan
guatemala
Bolivia
Azerbaijan
Mexico
Cuba
Colombia
Myanmar
Guatemala
Panama
Bolivia
Philippines
Kenya
Chile
Ecuador
Ethopia
Nepal
Liberia
Vietnam
Turmenistan
Uzbekistan